Profile

Michael D. Chan, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

179 Ratings
18 Comments
 

Michael D. Chan, M.D.

Associate Professor,

Clinical Interests

Brain Tumors

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: mchan@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., Johns Hopkins University, 1998
  • M.D., New York University School of Medicine, 2004

Board Certifications

  • American Board of Radiology, Radiation Oncology

NPI Number

  • 1225151152
Michael D. Chan, M.D.

Doctor Rating

4.7 out of 5

179 Ratings
18 Comments
 

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: mchan@wakehealth.edu

Recent Publications

Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S. Biology and treatment of metastasis of sarcoma to the brain. Front Biosci (Elite Ed). 2016;8():233-244.

Devoid HM, McTyre ER, Page BR, Metheny-Barlow L, Ruiz J, Chan MD. Recent advances in radiosurgical management of brain metastases. Front Biosci (Schol Ed). 2016;8():203-214.

Haughton ME, Chan MD, Watabe K, Bonomi M, Debinski W, Lesser GJ, Ruiz J. Treatment of brain metastases of lung cancer in the era of precision medicine. Front Biosci (Elite Ed). 2016;8():219-232.

Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW. Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers (Basel). 2016;8(2):E22.

McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD. Emerging indications for fractionated gamma knife radiosurgery. Neurosurgery. 2016;():.

Zhang J, Yu H, Qian X, Liu K, Tan H, Yang T, Wang M, Li KC, Chan MD, Debinski W, Paulsson A, Wang G, Zhou X. Pseudo progression identification of glioblastoma with dictionary learning. Comput Biol Med. 2016;73():94-101.

Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS. Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res. 2015;21(2):286-294.

Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015;22(3):561-565.

Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan M, Zhou X, Qasem S, Pochampally R, Mo YY, Watabe K. Roles of the cyclooxygenase 2-matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J Biol Chem. 2015;290(15):9842-9854.

Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536-542.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol. 2015;123(1):171-177.

Rapp SR, Case LD, Peiffer A, Naughton MM [sic] [Naughton MJ], Chan MD, Stieber VW, Moore DF Jr, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG. Donepezil for irradiated brain tumor survivors: a phase III randomized placebo-controlled clinical trial. J Clin Oncol. 2015;33(15):1653-1659.

Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015;17(10):1393-1401.

Chan MD. Recent technical advances and indications for radiation therapy in low-grade glioma. Semin Radiat Oncol. 2015;25(3):189-196.

Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015;6(22):18945-55.

Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW. Repeat radiosurgery for trigeminal neuralgia. Neurosurgery. 2015;77(5):755-761.

Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G. Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. J Clin Oncol. 2015;33(15 Suppl):e20669.

Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD. Factors that determine local control with gamma knife radiosurgery: the role of primary histology. J Radiosurg SBRT. 2015;3(4):281-286.

Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. J Neurooncol. 2015;124(3):447-453.

Smith CA, McTyre E, Isom S, Kennedy VE, Luo G, Morales-Paliza M, Hinson W, Cmelak AJ, Tatter SB, Chan MD, Attia A. A multi-institutional analysis of patients treated with stereotactic radiosurgery for brain metastases from radioresistant histologies [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3):E87-E88.

McTyre E, Johnson A, Ruiz J, Isom S, Lucas JT Jr, Hinson W, Watabe K, Laxton AW, Tatter SB, Chan MD. A competing risks analysis assessing predictors of neurologic and non-neurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S176.

McTyre E, Lucas JT Jr, Helis C, Farris M, Houseknecht K, Mott R, Laxton AW, Tatter SB, Lesser GJ, Chan MD. Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E108.

Gorovets D, Ayala-Peacock DN, Tybor DJ, Rava PS, Ebner DK, Chan MD, Hepel JT. Multi-institutional nomogram predicting survival free from salvage whole-brain radiation after radiosurgery for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E77.

Lucas JT Jr, Lack C, Wagner B, Kuremsky JG, Mu F, Chan MD, Sweeney A, Maldjian J, Whitlow C. A comprehensive assessment of radiographic, clinical, and treatment related risk factors for metastasis related intracranial hemorrhage in metastatic melanoma following radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E111.

Houseknecht K, Taksler GB, Johnson A, Page BR, Hinson W, Laxton AW, Tatter SB, Weaver KE, Chan MD, Ruiz J. Impact of socioeconomic status on brain metastasis outcomes at a large academic radiosurgery center [abstract]. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E366.

Greene-Schloesser D, Payne V, Peiffer AM, Hsu FC, Riddle DR, Zhao W, Chan MD, Metheny-Barlow L, Robbins ME [deceased]. The peroxisomal proliferator-activated receptor (PPAR) alpha agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat Res. 2014;181(1):33-44.

Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014;120(3):433-441.

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014;37(2):177-181.

Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T [deceased], Blevins M, High K, Lesser GJ. Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol. 2014;16(12):1639-1644.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014;16(9):1283-1288.

Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg. 2014;82(6):1250-1255.

Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, Wazer DE, Yao KC, Wu JK, Duker JS. Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. Ophthalmic Surg Lasers Imaging Retina. 2014;45(2):125-131.

Leyrer CM, Chan MD, Peiffer AM, Horne E, Harmon M, Carter AF, Hinson WH, Mirlohi S, Duncan SE, Dietrich AM, Lesser GJ. Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol. 2014;4(2):130-135.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.

Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol. 2014;120(1):163-169.

Kuhn EN, Taksler GB, Dayton O, Loganathan A, Bourland D, Tatter SB, Laxton AW, Chan MD. Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis. Neurosurgery. 2014;75(5):536-545.

Lucas JT, DiNotto J, Dolesh W, Jung Y, Whitlow CT, Maldjian JA, Chan MD, Bourland J. Safety assessment, artifact reduction, and description of geometric distortion associated with diffusion imaging (DWI) with rigid head frame immobilization for stereotactic radiosurgery [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(1 Suppl):S903.

Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD. Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S245.

Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD. Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD. Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

Lucas JT, Ayala-Peacock DN, Piazza M, Kuremsky JG, Page BR, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD. A propensity score adjusted analysis of patients receiving up-front SRS versus WBRT: does the use of upfront WBRT really affect neurologic death? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S315-S316.

Ayala-Peacock DN, Attia A, Hepel J, Lucas JT, Onyeuku N, Stavas MJ, Taylor RB, Chung C, Fiveash J, Chan MD. A multi-institutional predictive nomogram for distant brain failure in patients treated with upfront stereotactic radiosurgery without whole brain radiation therapy [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S126.

Attia A, Page BR, Lesser GJ, Chan M. Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol. 2014;15(4):539-550.

Okada H, Butterfield L, Hamilton R, Ahn B, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively M, Chan M, Salazar A, Shaw E, Potter D, Lieberman F. Induction of robust type-1 CD8(+) T-cell responses in WHO grade II low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC [abstract]. Neuro Oncol. 2014;16(Suppl 5):v114.

Strowd R, Russell G, Harmon M, Carter A, Chan M, Tatter S, Laxton A, High K, Lesser G. A pilot study of high-dose influenza vaccine immunogenicity in patients with primary central nervous system malignancy [abstract]. Neuro Oncol. 2014;16(Suppl 5):v207.

Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747-753.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Radiation Oncology

Clinical Interests

Brain Tumors
Michael D. Chan, M.D.

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Doctor Rating

4.7 out of 5

Michael D. Chan, M.D.179 Ratings
18 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/26/2016

Even though you have bad news, they are so nice and make you feel it will be OK - *Dr. Chan is EXCELLENT!

5/25/2016

*Dr. Chan was very nice and willing to answer questions that I had. He couldn't been any nicer. Thank you.

5/24/2016

very good and uplifting

5/10/2016

Dr. Chan was very reassuring and knowledgeable...awesome Dr

4/26/2016

good

3/4/2016

*Dr. Chan very professional & easy going. Makes patient to be relaxed & comfortable to communicate with. (PBC)

3/1/2016

Very compassionate and answered all of our questions

2/24/2016

Very good.

2/22/2016

Everything went very well.

2/18/2016

good

2/15/2016

Good.

1/12/2016

Good.

1/7/2016

Dr Chan is a most excellent provider. I have complete confidence in his care. He is skilled and competent and makes me feel confident in the care I receive from him. He shows genuine concern for my illness and life goals. I can't say enough good things about dr chan. He gets the impact he has in patients!

12/15/2015

Dr Chan and staff are wonderful

11/17/2015

Dr. Chan is a phenomenal doctor. I would recommend him to everyone I know. He is kind and he is brilliant. I am healed of cancer because of him and my medical team at Wake Forest Baptist Health.

10/6/2015

Dr. Chan is great & very helpful with Elizabeth's care & progress!

9/29/2015

*Dr. Chan has provided us with superior care - Both technically & in terms of communication/EQ.

9/28/2015

Always good.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.